Access

Article


Nature Medicine 13, 62 - 69 (2006)
Published online: 10 December 2006 | doi:10.1038/nm1519

NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF

Bae Keun Park1, Honglai Zhang1, Qinghua Zeng1, Jinlu Dai2, Evan T Keller2, Thomas Giordano3, Keni Gu4, Veena Shah4, Lei Pei4, Richard J Zarbo4, Laurie McCauley3,5, Songtao Shi6, Shaoqiong Chen1 & Cun-Yu Wang1


Advanced breast cancers frequently metastasize to bone, resulting in osteolytic lesions, yet the underlying mechanisms are poorly understood. Here we report that nuclear factor–kappaB (NF-kappaB) plays a crucial role in the osteolytic bone metastasis of breast cancer by stimulating osteoclastogenesis. Using an in vivo bone metastasis model, we found that constitutive NF-kappaB activity in breast cancer cells is crucial for the bone resorption characteristic of osteolytic bone metastasis. We identified the gene encoding granulocyte macrophage–colony stimulating factor (GM-CSF) as a key target of NF-kappaB and found that it mediates osteolytic bone metastasis of breast cancer by stimulating osteoclast development. Moreover, we observed that the expression of GM-CSF correlated with NF-kappaB activation in bone-metastatic tumor tissues from individuals with breast cancer. These results uncover a new and specific role of NF-kappaB in osteolytic bone metastasis through GM-CSF induction, suggesting that NF-kappaB is a potential target for the treatment of breast cancer and the prevention of skeletal metastasis.


MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Highlights

Clinical Pharmacology & Therapeutics News and Views

Bone-breaking cancer treatment

Nature Medicine News and Views (01 Jan 2007)

See all 4 matches for News And Views